别名 Epidermoid Cell Carcinoma of Lung、Epidermoid Cell Carcinoma of the Lung、Epidermoid Cell Lung Carcinoma + [38] |
简介 A carcinoma arising from squamous bronchial epithelial cells. It may be keratinizing or non-keratinizing. Keratinizing squamous cell carcinoma is characterized by the presence of keratinization, pearl formation, and/or intercellular bridges. Non-keratinizing squamous cell carcinoma is characterized by the absence of keratinization, pearl formation, and intercellular bridges. Cigarette smoking and arsenic exposure are strongly associated with squamous cell lung carcinoma. |
靶点 |
作用机制 EGFR拮抗剂 |
在研机构 |
原研机构 |
最高研发阶段临床3期 |
首次获批国家/地区- |
首次获批日期1800-01-20 |
作用机制 Phosphatidylinositol 3-kinase family inhibitors [+1] |
在研机构 |
原研机构 |
在研适应症 |
最高研发阶段临床3期 |
首次获批国家/地区- |
首次获批日期1800-01-20 |
作用机制 EGFR拮抗剂 [+1] |
在研机构 |
原研机构 |
非在研适应症- |
最高研发阶段临床3期 |
首次获批国家/地区- |
首次获批日期1800-01-20 |
开始日期2024-08-22 |
开始日期2024-06-01 |
申办/合作机构- |
开始日期2024-05-01 |
申办/合作机构 |